Essais liés2clinical trials
VilleCalgarylocalisation
PaysCanadalocalisation
SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT01194570

Ouvrir le site du centre

Essais cliniques associés

2
MoléculeIndication / populationPhaseNCTTitreStatut
PREDICT — Patient Reported Outcomes in Patients With Chronic Migraine Treated With BOTOX® Migraine À vérifier NCT02502123 PREDICT — Patient Reported Outcomes in Patients With Chronic Migraine Treated With BOTOX® COMPLETED
Ocrelizumab SEP Phase 3 NCT01194570 ORATORIO — A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis COMPLETED